EyePoint Pharmaceuticals Inc

The current institutional shareholding score of EyePoint Pharmaceuticals Inc is 10.00, ranking 1 out of 157 in the Pharmaceuticals industry. The latest institutional shareholding proportion is 105.59%, representing a quarter-over-quarter decrease of 16.25%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.14% of shares outstanding, with 0.07% increase in holdings.